Today it was announced that Clenergen Corporation India Private Limited, a wholly owned subsidiary of Clenergen Corporation, has agreed on the terms to acquire a 1.5MW/Hr biomass power plant in Namakkal, Tamilnadu, which will be operational by yearend 2009.

Recognized as one of India’s National Demonstration Projects, the plant was shut down in 2007 due to operational cash flow constraints and its inability to remain profitable at a low tariff rate. However, under a Power Purchase Agreement between Power Trading Corporation of India Limited (PTC) and Clenergen India Private Limited, a higher tariff rate has now been agreed.

The unit is expected to generate net revenue of approximately US$1 million in its first year of operation. During the first phase of its operations in India, Clenergen will ramp up the capacity of this power plant to 10MW/Hr while installing two new biomass

Earlier this year, Clenergen Corp. announced its first major power purchase agreement with the Power Trading Corporation (NASDAQ: PTC) of India for the purchase and sale of 71 MW of power, which is to be generated by Clenergen’s new biomass based power project in Tamilnadu. This purchase agreement has a value of up to $80.0 MM USD per year for 15 years, totaling to $1.2 Billion.

Clenergen India’s Honorary Chairman Dr. Arvind Pandalai, who has helped formulate various policies of the Government of India over a 32 year career, believes that his home country is the ideal place for Clenergen to initiate its global agenda. He stated, “The expertise of Clenergen’s management team and the strength of its proposition at a time when India and the rest of the world is demanding cleaner, more accessible electricity are truly compelling.”

The residential and business

Clenergen Corp. CEO Mark Quinn announced today before the opening that the company has acquired an exclusive intellectual property license for use in India and Sri Lanka from Star Biotechnology Ltd. This license will provide immediate access to the technology and knowledge required to increase the rate of biomass production, assisting in the generation of clean electricity through gasification.

“This is a significant source of plant science and expertise for Clenergen and will literally accelerate the development of our ambitions in the field. We have been working with the science team for the past six months and I am glad to have now reached this milestone”, stated Mr. Quinn today.

Using mother strains of Paulownia originating from Australia, the Polyploidy Technology Plant Adaption Process (PTPAP) will be applied to produce an entirely new species of fast growing tree, specifically cultivated to thrive in the climate and soils of land leased

Today, Clenergen Corporation announced that it will acquire 100% controlling interest of UK-based Clenergen Corporation Limited, intending to establish the corporation as a global leader of Biomass Power Generation Companies.

CCL currently retains 100% controlling interest in Clenergen India Private Limited, a subsidiary company based in Chennai, designed to implement a 80MW per hour Biomass Power Plant. Recently, Clenergen India signed a 15 year Power Purchase Agreement with the Power Trading Corporation of India Limited, valued at $87,000,000 per year. The company has secured leases on 4000 acres of land in Tamilnadu and is in the process of obtaining land leases from the Government of Karnataka to cultivate 25,000 acres for the production of biomass from bamboo cultivation. Clenergen India is projected to float on the National Stock Exchange in India in December 2009 and intends to have engaged Ernst and Young to raise its debt and private equity requirements.

In